ELEV — Elevation Oncology Share News
0.000.00%
Last trade - 00:00U.S. RESEARCH ROUNDUP- Crane, Ryder System, Terex
Brief: Elevation Oncology Says Concentra To Buy Elevation Oncology For $0.36 Per Share Plus CVR
Elevation Oncology Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Elevation Oncology Inc - To Prepay Term Loan Under Loan & Security Agreement Dated July 27, 2022 - SEC Filing
U.S. RESEARCH ROUNDUP-Darden Restaurants, Nike, Optinose
U.S. STOCKS ON THE MOVE-Accenture, Nike, FedEx
U.S. STOCKS ON THE MOVE-KKR, Micron Technology, Eli Lilly
Elevation Oncology tumbles after halting development of cancer drug
Elevation Oncology Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Elevation Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Achievements
Elevation Oncology Inc expected to post a loss of 22 cents a share - Earnings Preview
Brief: Elevation Oncology Provides Updates On Differentiated Adc Programs And Upcoming Milestones
Brief: Synaffix Elevation Oncology Licenses ADC Technology From Synaffix To Drive Pipeline Expansion
Brief: Elevation Oncology Expands Pipeline With Nomination Of EO-1022
Brief: Elevation Oncology Receives Fast Track Designation from the FDA for EO-3021 for the Treatment of Adult Patients with Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer Expressing Claudin 18.2
Brief: Elevation Oncology On Sept 18, Got Notice From Nasdaq On Co's Failure To Satisfy A Continued Listing Rule Or Standard
U.S. STOCKS ON THE MOVE-IDEXX, Amgen, Airbnb
U.S. STOCKS ON THE MOVE-Lumen Technologies, Broadridge Financial, IDEXX
Elevation Oncology Inc reports results for the quarter ended in June - Earnings Summary